TY  - JOUR
AU  - Ramos-Goni, JM
AU  - Oppe, M
AU  - Stolk, E
AU  - Shah, K
AU  - Kreimeier, S
AU  - Rivero-Arias, O
AU  - Devlin, N
Y2  - 2020/11/26
Y1  - 2020/04/16
SN  - 1170-7690
UR  - http://hdl.handle.net/11343/252049
AB  - The EQ-5D-Y-3L is a generic, health-related, quality-of-life instrument for use in younger populations. Some methodological studies have explored the valuation of children's EQ-5D-Y-3L health states. There are currently no published value sets available for the EQ-5D-Y-3L that are appropriate for use in a cost-utility analysis. The aim of this article was to describe the development of the valuation protocol for the EQ-5D-Y-3L instrument. There were several research questions that needed to be answered to develop a valuation protocol for EQ-5D-Y-3L health states. Most important of these were: (1) Do we need to obtain separate values for the EQ-5D-Y-3L, or can we use the ones from the EQ-5D-3L? (2) Whose values should we elicit: children or adults? (3) Which valuation methods should be used to obtain values for child's health states that are anchored in Full health = 1 and Dead = 0? The EuroQol Research Foundation has pursued a research programme to provide insight into these questions. In this article, we summarized the results of the research programme concluding with the description of the features of the EQ-5D-Y-3L valuation protocol. The tasks included in the protocol for valuing EQ-5D-Y-3L health states are discrete choice experiments for obtaining the relative importance of dimensions/levels and composite time-trade-off for anchoring the discrete choice experiment values on 1 = Full Health and 0 = Dead. This protocol is now available for use by research teams to generate EQ-5D-Y-3L value sets for their countries allowing the implementation of a cost-utility analysis for younger populations.
LA  - English
PB  - ADIS INT LTD
T1  - International Valuation Protocol for the EQ-5D-Y-3L
DO  - 10.1007/s40273-020-00909-3
IS  - PharmacoEconomics
VL  - 38
IS  - 7
SP  - 653-663
L1  - /bitstream/handle/11343/252049/s40273-020-00909-3.pdf?sequence=1&isAllowed=y
ER  -